Autor: |
Georges Vauquelin, Géza Tóth, Jean-Paul De Backer, Erzsébet Szemenyei, Heidi Demaegdt, Aneta Lukaszuk, Dirk Tourwé |
Rok vydání: |
2011 |
Předmět: |
|
Zdroj: |
Fundamental & Clinical Pharmacology. 26:194-197 |
ISSN: |
0767-3981 |
DOI: |
10.1111/j.1472-8206.2011.00948.x |
Popis: |
Radioligand binding studies revealed that Ang IV binds to insulin-regulated aminopeptidase (IRAP)/'AT(4) receptors' with high affinity. Yet, as these experiments were routinely carried out in the presence of chelators, only the catalytic zinc-depleted apo-form of IRAP was labelled. While the chelators remove the catalytic zinc from IRAP and protect Ang IV from proteolytic degradation, the aminopeptidase N selective inhibitor '7B' only exerts the latter effect. By using 7B along with the new stable Ang IV-analog [(3) H]AL-11, we here show that the native enzyme is only a low-affinity target for Ang IV. |
Databáze: |
OpenAIRE |
Externí odkaz: |
|